Fundz Deep Dive
Everything you need to win Quibim — in one platform.
Who to reach, what to say, and why now on Quibim — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Quibim — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Quibim Announces Partnership with Asabys and Buenavista to Revolutionize Precision Medicine with AI-Powered Imaging Biomarkers
Contract Type
partnership
Description
Quibim, in partnership with Asabys and Buenavista, has closed a $50 million Series A financing to revolutionize precision medicine with AI-powered imaging biomarkers. The financing was driven by several regulatory approvals and global commercial partnerships, leading to a surge in patient analysis. Quibim's AI-enabled insights from MRI, CT, and PET scans are already being used by doctors to detect early signs of diseases like cancer and help measure treatment response.